PET and [F-18]-FDG in oncology: A clinical update
PET and [F-18]-FDG in oncology: A clinical update
复制标题
DOI：
10.1016/0969-8051(96)00074-1
复制
发表时间：
1996-08-01
影响因子：
3.1
通讯作者：
Bading, JR
中科院分区：
文献类型：
--
作者：
Conti, PS;Lilien, DL;Bading, JR
正电子发射断层扫描（PET）已经成为一种非常有用的辅助解剖成像技术，为疾病的表征增加了独特的信息。在过去几年中发展起来的全身PET FDG技术在临床肿瘤学方面的应用已经超出了大多数人的预期。现在可以用这种方法研究大范围的肿瘤，使其成为许多癌症患者诊断和管理中必不可少的临床成像工具。该技术提供的代谢信息是对标准临床和形态学检查结果的补充。可以预见，通过多模态成像方法的应用，将在医疗保健方面取得重大进展。
Positron emission tomography (PET) has become a very useful adjunct to anatomic imaging techniques, adding unique information to the characterization of disease. The whole-body PET FDG technique developed over the last few years has surpassed most expectations with respect to its utility in clinical oncology. The large spectrum of neoplasms that now can be studied with this approach makes it an essential clinical imaging tool in diagnosis and management for many patients with cancer. The metabolic information provided by this technique is complementary to results from standard clinical and morphological examinations. It may be anticipated that through application of the multi-modality imaging approach, significant advances in medical care will come.